Feline Demodicosis (Demodex cati and Demodex gatoi Infestation)

Feline demodicosis is an uncommon parasitic skin disease of domestic cats caused by mite species belonging to the genus Demodex. Two well-characterized species are recognized: Demodex cati (Mégnin, 1877), a hair follicle-dwelling mite, and Demodex gatoi (Desch & Stewart, 1999), a surface-dwelling mite residing in the stratum corneum [2]. A third, as-yet formally unnamed Demodex species has also been documented in cats, representing an area of ongoing taxonomic investigation [4][8]. Unlike canine demodicosis, feline demodicosis is relatively rare and, particularly in the case of D. cati, is frequently associated with underlying immunosuppressive conditions such as feline immunodeficiency virus (FIV) infection, diabetes mellitus, or prolonged corticosteroid use [1][3]. Demodex gatoi is notable for being contagious between cats and for producing a characteristically pruritic clinical presentation [2][5].

The Causative Mites

Demodex cati is an elongate, vermiform mite that inhabits hair follicles and sebaceous glands of the skin. It is considered a normal commensal resident of feline skin at low population densities, analogous to Demodex canis in dogs [2]. Disease results when immune dysregulation or systemic illness allows the mite population to proliferate beyond subclinical levels.

Demodex gatoi, formally described as a new species in 1999, is morphologically distinct from D. cati — it is shorter-bodied and resides on the epidermal surface within the stratum corneum rather than inside hair follicles [2]. A striking feature noted at its initial description was that more than half of the D. gatoi population sampled consisted of ova, indicating the capacity for rapid population growth [2]. D. gatoi is capable of direct transmission between cats, making it the contagious form of feline demodicosis [5][6].

A third unnamed Demodex species has been identified in cats and is morphologically and molecularly distinct from both D. cati and D. gatoi [4][8]. This species appears to have different topographic specificity on the host and represents the most recently characterized member of feline-associated Demodecidae.

Pathological Mechanism

• ·

  Immunosuppression and D. cati: Proliferative D. cati infestation in cats is strongly associated with underlying immunocompromising conditions. Documented predisposing causes include FIV infection [1][3], feline leukemia virus (FeLV) infection, diabetes mellitus, hyperadrenocorticism, neoplasia, and iatrogenic immunosuppression from prolonged corticosteroid administration [7]. The mite exploits deficits in cell-mediated immunity to escape normal host-controlling mechanisms.

• ·

  Morphological variability: Demodex mites can exhibit unusual morphological forms in the context of immune compromise. Molecular characterization using 16S rRNA-based PCR has been instrumental in correctly identifying unusual mite morphotypes as D. cati rather than novel species, highlighting the importance of molecular tools in diagnosis [1][7].

• ·

  Contagiousness of D. gatoi: Unlike D. cati, D. gatoi spreads readily between cats via direct contact. Fecal flotation has been shown to be a useful method for detecting D. gatoi, as mites are ingested during grooming and pass through the gastrointestinal tract [5][8]. Pruritus associated with D. gatoi infestation is partly attributed to the surface location of the mite stimulating cutaneous sensory receptors and triggering hypersensitivity responses.

• ·

  Host specificity: Demodex mites exhibit high host, topical, and topographic specificity, meaning each species is adapted to a particular host species and a particular microhabitat on that host [4]. Cats may harbor multiple Demodex species simultaneously, as demonstrated in cases where both D. cati and D. gatoi were found concurrently in immunocompromised individuals [2][3].

• ·

  Molecular taxonomy: PCR-based assays using the 16S rRNA gene have been developed to detect and differentiate all three known feline Demodex species in a single reaction, resolving ambiguity inherent in morphological identification alone [6][8]. Phylogenetic analysis has clarified the relationships among feline demodecid mites and confirmed the distinctiveness of the third unnamed species [8].

Clinical Diagnosis

A tentative diagnosis of feline demodicosis is based on history, signalment, clinical signs, and identification of predisposing conditions. Any cat presenting with alopecia, pruritus, scaling, or comedones — especially in the context of known immunosuppressive disease — should be evaluated for Demodex infestation [1][3]. Cats with D. gatoi infestation may show intense pruritus that could initially be confused with allergic dermatitis or other ectoparasitic infestations.

Skin Scrapings

• ·Superficial skin scrapings: The diagnostic method of choice for D. gatoi, given its surface-dwelling habitat in the stratum corneum. Scrapings should be wide and superficial over affected areas, collected until capillary bleeding is approached [3].
• ·Deep skin scrapings: Required for D. cati detection, as this species inhabits hair follicles. The scraping should be vigorous enough to express follicular contents [3].
• ·Smears are mounted in mineral oil and examined under low-power microscopy. Identification is made by mite morphology: D. cati is longer and follicular; D. gatoi is shorter and surface-dwelling [2].

Fecal Flotation

Because cats groom and ingest D. gatoi mites, fecal flotation using a standard zinc sulfate or sugar solution can detect D. gatoi eggs, larvae, nymphs, or adults in feces [5][8]. This is a particularly valuable diagnostic adjunct when skin scrapings are negative but clinical suspicion remains high. The first reported case of D. gatoi in Austria was detected exclusively by fecal flotation [5].

Trichoscopy / Hair Plucks

Hair plucking (trichoscopy) may be useful to identify mites at the base of hair shafts, particularly for D. cati.

Molecular / PCR-Based Diagnostics

PCR amplification targeting the 16S rRNA mitochondrial gene provides a sensitive and specific method for detecting and differentiating D. cati, D. gatoi, and the third unnamed feline Demodex species [6][7][8]. A quantitative PCR (qPCR) assay capable of simultaneously discriminating all three species in a single reaction has been described [8]. Molecular diagnostics are particularly useful when:

• ·Mite numbers are low and microscopy yields ambiguous or negative results [6]
• ·Morphologically atypical mites are found [1][7]
• ·Species-level identification is required for epidemiological purposes

Evaluation for Underlying Disease

All cats diagnosed with D. cati-associated demodicosis should undergo a thorough work-up for immunosuppressive conditions, including:

• ·Retroviral testing: FIV antibody test and FeLV antigen test
• ·Blood glucose: Rule out diabetes mellitus
• ·Complete blood count (CBC): Assess for cytopenias, neutrophilia, or abnormalities suggestive of hematological disease; anemia (low HCT), thrombocytopenia (low PLT), or leukopenia (low WBC) may indicate retroviral infection or myelosuppression [3]
• ·Serum biochemistry panel: Elevated ALT may suggest hepatic involvement; elevated BUN and CREA may indicate concurrent renal disease; hypoalbuminemia (low ALB) and hyperglobulinemia (elevated GLOB) may be consistent with chronic infection or neoplasia
• ·Cortisol/ACTH stimulation testing: If hyperadrenocorticism is suspected
• ·Urinalysis: Including urine glucose for diabetes screening
• ·Thoracic and abdominal imaging: To rule out occult neoplasia

Histopathology

Skin biopsy with histopathological evaluation can demonstrate mites within hair follicles (D. cati) or the stratum corneum (D. gatoi), and characterize the degree of perifollicular and dermal inflammation. This is useful when scrapings are inconclusive.

Treatment of Demodex gatoi

Because D. gatoi is contagious and surface-dwelling, treatment must address all in-contact cats in the household simultaneously [5].

• ·Lime sulfur dips (2–3% sulfurated lime solution): Historically the most consistently effective treatment for D. gatoi. Applied weekly as a whole-body rinse for a minimum of 6–8 weeks. All cats in the household must be treated concurrently.
• ·Amitraz: Has been used off-label in cats, though it carries significant risk of toxicity in this species and is used cautiously, generally at lower concentrations than in dogs. Use is controversial and should only be undertaken with careful monitoring.
• ·Doramectin: Weekly subcutaneous injections have been reported effective in some cats with D. gatoi.
• ·Selamectin (Revolution): A topical macrocyclic lactone applied monthly; some reports suggest efficacy against D. gatoi in cats, though evidence is variable.
• ·Moxidectin/imidacloprid (Advocate/Advantage Multi): Topical spot-on formulations have shown promise for D. gatoi in clinical case reports.
• ·Environmental management: Thorough cleaning of the environment to reduce mite burden, including bedding and shared surfaces.

Treatment of Demodex cati

• ·Identify and treat underlying immunosuppressive disease: This is the cornerstone of managing D. cati-associated demodicosis. If immunosuppression can be corrected (e.g., dose reduction of corticosteroids, glycemic control in diabetics), the mite infestation may resolve or become more amenable to acaricidal treatment [1][7].
• ·Topical amitraz washes or lime sulfur dips: Applied to affected areas or whole-body depending on extent of disease.
• ·Ivermectin: Oral or subcutaneous ivermectin has been used in some cases, though cats are sensitive to ivermectin toxicity and it should be used cautiously at veterinary-recommended doses.
• ·Moxidectin/imidacloprid spot-on: May assist in reducing D. cati burden.
• ·Isoxazolines (e.g., fluralaner, sarolaner): Emerging evidence in dogs supports isoxazoline use for demodicosis; use in cats is being investigated and shows promise but robust feline-specific data remain limited.

Supportive and Adjunctive Therapy

• ·Antiseptic shampoos or rinses: To address secondary bacterial pyoderma if present.
• ·Antibiotics: Systemic antibiotics (e.g., amoxicillin-clavulanate, doxycycline) if secondary bacterial infection is confirmed.
• ·Anti-inflammatory therapy: Should be used cautiously; corticosteroids are generally contraindicated as they may worsen underlying immunosuppression and exacerbate D. cati overgrowth.
• ·Nutritional support: For cats with concurrent systemic illness and weight loss [1].

Monitoring Response

Treatment response is monitored by serial skin scrapings (and/or fecal flotation for D. gatoi) performed monthly. PCR-based testing can be used to confirm mite clearance in difficult or ambiguous cases [6][8]. Treatment should be continued for at least 4 weeks beyond the first negative scraping result.

Data on long-term survival statistics specific to feline demodicosis are limited in the current veterinary literature, and no peer-reviewed case-fatality statistics for the disease itself were identified in the references cited above. However, clinically relevant prognostic considerations are well-supported:

• ·

  Demodex gatoi infestation: The prognosis for resolution is generally favorable when all in-contact cats are treated concurrently and treatment is maintained for an adequate duration. Recurrence is possible if treatment is discontinued prematurely or if re-exposure occurs [5][6].

• ·

  Demodex cati infestation: Prognosis is heavily dependent on the nature and reversibility of the underlying immunosuppressive disease [1][3][7].

  • ·Cats with iatrogenic immunosuppression (e.g., steroid-treated for erythroid dysplasia [7]) may achieve resolution once the underlying cause is addressed or steroids are tapered.
  • ·Cats with FIV-associated demodicosis carry a guarded long-term prognosis related to their underlying retroviral infection rather than the demodicosis per se [1][3]. FIV is a chronic, progressive disease, and demodicosis in these patients may recur or be difficult to fully eliminate.
  • ·Cats with concurrent diabetes mellitus may achieve good control of demodicosis if glycemia is well managed.
  • ·Cats with neoplastic or other advanced systemic disease have a more guarded to poor prognosis overall.
• ·

  Morphological variability and unusual presentations: Cases with morphologically atypical mites in immunocompromised hosts (e.g., FIV-positive cats) do not necessarily imply a worse prognosis for the demodicosis itself, but reflect the degree of immune compromise [1].

• ·

  Mortality directly from demodicosis: Feline demodicosis is not considered a directly life-threatening condition in itself. Deaths, when they occur in affected cats, are attributable to the underlying predisposing disease rather than the parasitic infestation.

There are currently no commercially available vaccines against feline Demodex species, and prevention relies on management strategies targeting both the mite and predisposing risk factors.

• ·Control of Demodex gatoi transmission: Because D. gatoi is contagious between cats, preventing direct contact between infested and healthy cats is important [2][5]. New cats should be quarantined and screened before introduction to a multi-cat household or cattery.
• ·Household-wide treatment: In multi-cat households with confirmed D. gatoi, all cats — including apparently asymptomatic individuals — should be treated, as some cats may be subclinical carriers [5][6].
• ·Maintaining immune health: Since D. cati proliferates in immunocompromised hosts, maintaining overall health and minimizing unnecessary immunosuppression (e.g., judicious use of corticosteroids) is important. Regular veterinary check-ups allow early detection of predisposing conditions such as diabetes or retroviral disease [1][7].
• ·Retroviral testing: Routine FIV and FeLV screening as part of preventive care allows earlier identification of immunosuppressed cats at risk for opportunistic demodicosis [1][3].
• ·Hygiene and environmental management: Regular cleaning of shared bedding, grooming tools, and living spaces may help reduce environmental mite loads, particularly for D. gatoi [5].
• ·Molecular screening tools: In high-risk populations such as research colonies or catteries, PCR-based screening can detect subclinical D. gatoi carriage and allow preemptive management before clinical disease becomes apparent [6][8].